As of this month, the U.S. Food and Drug Administration (FDA) has approved the use of esketamine nasal spray as an adjunctive treatment modality for a novel application in major...
from Psych Central Professional https://ift.tt/31YHApi
via https://ifttt.com/ IFTTT
No comments:
Post a Comment